Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38295318.
- Also identified by DOI 10.1200/PO.23.00234 and PMC identifier 10843369.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the first case of pacritinib-withdrawal syndrome with in vitro elucidation of underlying mechanisms.
Medical subject headings
- Primary Myelofibrosis